PTAB Invalidates United Therapeutics Patent Relating To The

In Liquidia Techs., Inc. v. United Therapeutics Corp.,[1] the Patent Trial and Appeal Board ("the PTAB") held all challenged claims of U.S. Patent No. 10,716,793 ("the '793 patent") unpatentable under 35 U.S.C. § 103.

Related Keywords

, Liquidia Techs Inc , Fox Factory Inc , Liquidia Techs , Patent Trial , Appeal Board , United Therapeutic , Loreal United States , Mondaq , Ptab Invalidates United Therapeutics Patent Relating To The Hypertension Drug Tyvaso Xae , Intellectual Property , Patent ,